155 related articles for article (PubMed ID: 12177055)
1. Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs).
Richter W; Conti M
J Biol Chem; 2002 Oct; 277(43):40212-21. PubMed ID: 12177055
[TBL] [Abstract][Full Text] [Related]
2. The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases.
Richter W; Conti M
J Biol Chem; 2004 Jul; 279(29):30338-48. PubMed ID: 15131123
[TBL] [Abstract][Full Text] [Related]
3. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions.
Beard MB; Olsen AE; Jones RE; Erdogan S; Houslay MD; Bolger GB
J Biol Chem; 2000 Apr; 275(14):10349-58. PubMed ID: 10744723
[TBL] [Abstract][Full Text] [Related]
4. The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).
Xie M; Blackman B; Scheitrum C; Mika D; Blanchard E; Lei T; Conti M; Richter W
Biochem J; 2014 May; 459(3):539-50. PubMed ID: 24555506
[TBL] [Abstract][Full Text] [Related]
5. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
[TBL] [Abstract][Full Text] [Related]
6. ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions.
MacKenzie SJ; Baillie GS; McPhee I; Bolger GB; Houslay MD
J Biol Chem; 2000 Jun; 275(22):16609-17. PubMed ID: 10828059
[TBL] [Abstract][Full Text] [Related]
7. Dimerization of cAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains.
Bolger GB; Dunlop AJ; Meng D; Day JP; Klussmann E; Baillie GS; Adams DR; Houslay MD
Cell Signal; 2015 Apr; 27(4):756-69. PubMed ID: 25546709
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation.
Ang KL; Antoni FA
J Neurochem; 2002 May; 81(3):422-33. PubMed ID: 12065651
[TBL] [Abstract][Full Text] [Related]
9. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
[TBL] [Abstract][Full Text] [Related]
10. Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
Collins DM; Murdoch H; Dunlop AJ; Charych E; Baillie GS; Wang Q; Herberg FW; Brandon N; Prinz A; Houslay MD
Cell Signal; 2008 Dec; 20(12):2356-69. PubMed ID: 18845247
[TBL] [Abstract][Full Text] [Related]
11. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization.
Houslay MD; Adams DR
Biochem J; 2003 Feb; 370(Pt 1):1-18. PubMed ID: 12444918
[TBL] [Abstract][Full Text] [Related]
12. The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways.
Houslay MD; Baillie GS
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1186-90. PubMed ID: 14641023
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579.
Hill EV; Sheppard CL; Cheung YF; Gall I; Krause E; Houslay MD
Cell Signal; 2006 Nov; 18(11):2056-69. PubMed ID: 16973330
[TBL] [Abstract][Full Text] [Related]
14. The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site.
Grange M; Sette C; Cuomo M; Conti M; Lagarde M; Prigent AF; Némoz G
J Biol Chem; 2000 Oct; 275(43):33379-87. PubMed ID: 10938092
[TBL] [Abstract][Full Text] [Related]
15. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2.
Bolger GB; Peden AH; Steele MR; MacKenzie C; McEwan DG; Wallace DA; Huston E; Baillie GS; Houslay MD
J Biol Chem; 2003 Aug; 278(35):33351-63. PubMed ID: 12810716
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.
Sette C; Conti M
J Biol Chem; 1996 Jul; 271(28):16526-34. PubMed ID: 8663227
[TBL] [Abstract][Full Text] [Related]
18. In addition to the SH3 binding region, multiple regions within the N-terminal noncatalytic portion of the cAMP-specific phosphodiesterase, PDE4A5, contribute to its intracellular targeting.
Beard MB; Huston E; Campbell L; Gall I; McPhee I; Yarwood S; Scotland G; Houslay MD
Cell Signal; 2002 May; 14(5):453-65. PubMed ID: 11882390
[TBL] [Abstract][Full Text] [Related]
19. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
20. Investigation of extracellular signal-regulated kinase 2 mitogen-activated protein kinase phosphorylation and regulation of activity of PDE4 cyclic adenosine monophosphate-specific phosphodiesterases.
Hill EV; Houslay MD; Baillie GS
Methods Mol Biol; 2005; 307():225-37. PubMed ID: 15988067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
